Merger Monday Returns With Gilead, Oracle And NVIDIA In Focus

 | Sep 15, 2020 07:41AM ET

Global mergers and acquisitions had an abysmal second quarter this year as Covid-19 spread across the world.

According to Refinitiv, global M&A totaled $485.3 billion in the second quarter, a decline of 55% from the same period a year earlier. The total marks the lowest dollar amount for M&A activity since the third quarter of 2009, while the 8,272 deals in the second quarter marked the lowest quarterly deal volume since the third quarter of 2004.

The return of merger Monday yesterday provided a boost to the depressed M&A totals for the year as the third quarter nears an end. The $69 billion of deals announced over the weekend was the most since November 2019.

In the semiconductor industry's largest acquisition ever, Nvidia (NASDAQ:NVDA) agreed to acquire Arm Holdings from Softbank Group (T:9984) for $40 billion in cash and stock. The deal is a huge win for SoftBank, which bought Arm for $31.4 billion in 2016.

"AI is the most powerful technology force of our time and has launched a new wave of computing," Nvidia founder and CEO Jensen Huang said. "In the years ahead, trillions of computers running AI will create a new internet-of-things that is thousands of times larger than today's internet-of-people. Our combination will create a company fabulously positioned for the age of AI."

In the biotechnology sector, Gilead Sciences (NASDAQ:GILD) announced it will acquire Immunomedics (NASDAQ:IMMU) in a $21 billion deal to expand Gilead's availability of cancer treatments. The deal, which will be funded by cash and debt, caused shares of Immunomedics to soar more than 100% yesterday.